Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension.

Toshner M; Church C; Harbaum L; Rhodes C; Villar Moreschi SS; Liley J; Jones R; Arora A; Batai K; Desai AA

doi:10.1183/13993003.02463-2020

Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension.

Identifier:nobleid.org/w1/20260526/1DBEE030

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/1DBEE030.svg?ark=w1%2F20260526%2F1DBEE030)](https://nobleid.org/work/w1/20260526/1DBEE030)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension.

Identifier:nobleid.org/w1/20260526/1DBEE030

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/1DBEE030.svg?ark=w1%2F20260526%2F1DBEE030)](https://nobleid.org/work/w1/20260526/1DBEE030)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work